Linked Data API

Show Search Form

Search Results

1010188
star this property registered interest false more like this
star this property date less than 2018-11-19more like thismore than 2018-11-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading SecurMed: Fees and Charges more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the European Medicines Verification Organisation’s report, NMVO’s Fee Models Status, published on 21 August 2018, what discussions his Department has had with the UK's National Medicines Verification Organisation on reducing the entrance fees for small companies in line with those of other European countries. more like this
star this property tabling member constituency Sefton Central more like this
star this property tabling member printed
Bill Esterson remove filter
star this property uin 192829 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-11-22more like thismore than 2018-11-22
star this property answer text <p>SecurMed, the not-for-profit company set up by stakeholders in the United Kingdom medicines supply chain, is responsible for setting the fee model and level of fees as the UK’s National Medicines Verification Organisation (NMVO). In their supervisory capacity, the Medicines and Healthcare products Regulatory Agency (MHRA) and the Department’s aim is to ensure that SecurMed is complying with the regulation in a fair and proportionate way. As part of that role, the MHRA and the Department have been involved in discussions with SecurMed to challenge and seek to influence the pricing model to ensure that the UK’s fee structure is fair and proportionate.</p><p> </p><p>The European Commission has confirmed that the fee model being used by SecurMed is in line with the majority of other member states NMVO’s across the European Union. It is based on the number of users and cost per connection where larger organisations, which are more likely to have multiple marketing authorisations, pay more. An annual fee waiver scheme exists for micro Marketing Authorisation Holders which is designed to support start-ups and help ensure there is not a barrier to market entry.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
remove filter
star this property answering member
4065
star this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
4061
unstar this property label Biography information for Bill Esterson more like this